- Case Report
- Open Access
Cowden syndrome. Managing multiple skeletal metastases of different origin: a case report
© Angoules et al; licensee BioMed Central Ltd. 2008
- Received: 16 October 2008
- Accepted: 23 October 2008
- Published: 23 October 2008
Cowden Syndrome is a rare autosomal dominant multiple hamartomatous condition, characterised by both benign and malignant tumours affecting multiple systems.
We present a 47-year-old female patient with thigh pain that was diagnosed with Cowden syndrome 20 years ago and developed multiple and different skeletal metastases which became resistant to radio-chemotherapy. A percutaneous plate fixation of the distal femur with an intralesional excision and cementoplasty of the metastasis was performed initially. This was combined with a cemented total hip arthroplasty using an Exeter long revision stem and a cementoplasty of the femoral canal for the proximal lesions.
A meticulous approach to her complex metastatic disease resulted in successful palliative prophylactic reconstructive surgery that improved her quality of life, allowing her independent pain free walking for 12 months.
- Distal Femur
- Femoral Canal
- Cowden Syndrome
- Intralesional Excision
- PTEN Hamartoma Tumour Syndrome
Cowden Syndrome (CS) is a rare autosomal dominant disorder characterised by multiple hamartomas and an increased risk of breast, thyroid and endometrial carcinomas [1, 2] Germline mutations in the tumour suppressor gene PTEN (phosphatase and tensin homolog) chromosome 10q23.2, which codes for a lipid phosphate mediating cell cycle arrest and apoptosis, were first described in Cowden Syndrome In the next years since PTEN had been identified as the major CS susceptibility gene, a number of inherited cancer and developmental syndromes were associated with germline PTEN mutations. It has therefore been proposed that all such syndromes based on molecular defects are classified as PTEN Hamartoma Tumour Syndromes (PHTS)[2, 5]. Irrespective of clinical phenotype however, the discovery of a germline PTEN mutation should trigger cancer risk surveillance. Skeletal metastases of multiple origins are difficult to treat and palliative surgery usually requires a combination of approaches and techniques.
A 47-year-old female Caucasian patient presented with a right sided limp and ipsilateral thigh pain with an established diagnosis of CS according to the International Cowden Syndrome Consortium Operational Criteria1, positive for tumour suppressor phosphatase and tensin homolog gene (PTEN) mutation.
She was first diagnosed with thyroid follicular carcinoma and was treated with a thyroidectomy in 1989. The patient then developed breast cancer in 1991 for which she underwent lumpectomy followed by adjuvant radio-chemotherapy. Due to local recurrence the following year, she was treated with a left mastectomy and a few months later she underwent right nephrectomy for renal carcinoma. In 2003, she was diagnosed with left scapular renal metastatic and during the same year she developed brain metastases that required a right frontal lobe resection followed by whole brain radiotherapy. On presentation, she was known to have pulmonary and multiple bone metastases. Palliative skeletal radiotherapy was completed having exceeded the maximum radiation limits. As a last resort, she was on interferon treatment as well as bisphosphonates for palliation therapy.
Surgical planning and technique
Our patient presented with a long history of metastatic CS resistant to radio-chemotherapy. We elected to proceed to a combined surgical treatment of both the proximal and distal femoral metastases leaving the unaffected mid femur intact. A percutaneous plate fixation of the distal femur with an intralesional excision and cementoplasty of the metastasis was performed initially. This was combined with a cemented total hip arthroplasty using an Exeter long revision stem and a cementoplasty of the femoral canal. Weber et al recommended curettage with cementation and stabilization for metastatic renal cell carcinomas that are refractory to local adjuvants such as radiotherapy. They showed that this can decrease local progression of the disease. The same authors also advised embolization twelve to thirty six hours pre-operatively for renal cell and thyroid carcinomas especially if the procedure is performed without a tourniquet as in our case. Recently Fuchs et al reported no difference in the long-term survival between wide resection and intralessional curettage of renal cell metastases. However the functional morbidity of a widespread resection and reconstruction and its effect on weight-bearing should be considered and weighed against the potential prolongation of survival. Cemented THA with long stem femoral implant and cemented acetabular component are also recommended for metastatic long bone disease. Uncemented implants are contraindicated as the bone is biologically inert following previous or adjuvant radiotherapy and does not therefore allow ingrowth onto the implants. Cardiopulmonary compromise and thromboembolic events can be minimised by venting the femoral canal and lowering cement pressurisation .
In our case, preoperative biopsy or intraoperative frozen section biopsy were deemed unnecessary as the MRI features of the metastatic lesions were vascular and therefore of renal or thyroid origin.
Mirels classification system is a reliable method of predicting the likelihood of a pathological fracture and was used along with the clinical evaluation of the overall functional status of the patient to guide our treatment. We believe that by preserving the femur we have maintained the limb's functional capacity to a significant extent. That would possibly not have been the case if a widespread bone resection or a complex replacement reconstructive procedure had taken place. In addition to, our surgical approach allowed bone cementoplasty enhancement avoiding major resections, excessive blood loss and a high risk of postoperative infection.
This case reports on CS, a rare disease with multiple skeletal metastases of different origin. The treatment included a combination of cemented arthroplasty, cementoplasty and internal fixation that maintained function and improved our patient's quality of life.
Written informed consent was obtained from the patient's husband for publication of this case report and accompanying images in Journal of Medical Case Reports.
- Eng C: Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000, 37: 828-30. 10.1136/jmg.37.11.828.PubMed CentralView ArticlePubMedGoogle Scholar
- Eng C: PTEN: one gene, many syndromes. Hum Mutat. 2003, 22: 183-98. 10.1002/humu.10257.View ArticlePubMedGoogle Scholar
- Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997, 16: 64-7. 10.1038/ng0597-64.View ArticlePubMedGoogle Scholar
- Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C, et al: PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999, 8: 1461-72. 10.1093/hmg/8.8.1461.View ArticlePubMedGoogle Scholar
- Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman EC, Padberg GW, Kremer H: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997, 6: 1383-7. 10.1093/hmg/6.8.1383.View ArticlePubMedGoogle Scholar
- Nelen MR, Padberg GW, Peeters EA, Lin AY, Helm van den B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C: Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996, 13: 114-6. 10.1038/ng0596-114.View ArticlePubMedGoogle Scholar
- van Agt HM, Essink-Bot ML, Krabbe PF, Bonsel GJ: Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 1994, 39: 1537-44. 10.1016/0277-9536(94)90005-1.View ArticlePubMedGoogle Scholar
- Harris WH: Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969, 51: 737-55.PubMedGoogle Scholar
- Beck AT, Steer RA: Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984, 40: 1365-7. 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D.View ArticlePubMedGoogle Scholar
- Kvaal K, Ulstein I, Nordhus IH, Engedal K: The Spielberger State-Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients. Int J Geriatr Psychiatry. 2005, 20: 629-34. 10.1002/gps.1330.View ArticlePubMedGoogle Scholar
- Saklad M: Grading of patients for surgical procedures. Anaesthesiology. 1941, 281-4.Google Scholar
- Mirels H: Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989, 256-64.Google Scholar
- Weber KL, Randall RL, Grossman S, Parvizi J: Management of lower-extremity bone metastasis. J Bone Joint Surg Am. 2006, 88 (Suppl 4): 11-9. 10.2106/JBJS.F.00635.View ArticlePubMedGoogle Scholar
- Fuchs B, Trousdale RT, Rock MG: Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop Relat Res. 2005, 187-92. 10.1097/01.blo.0000149820.65137.b4.Google Scholar
- Randall RL, Aoki SK, Olson PR, Bott SI: Complications of cemented long-stem hip arthroplasties in metastatic bone disease. Clin Orthop Relat Res. 2006, 443: 287-95. 10.1097/01.blo.0000191270.50033.3a.View ArticlePubMedGoogle Scholar
- Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J: Critical evaluation of Mirels' rating system for impending pathologic fractures. Clin Orthop Relat Res. 2003, S201-7. 10.1097/01.blo.0000093842.72468.73.Google Scholar
- Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW: Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007, 89: 1794-801. 10.2106/JBJS.F.00603.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.